Rick E. Winningham, Chief Executive Officer at Theravance Biopharma, Inc. (TBPH), bought 10,000 shares at $24.50 ($245K) on 2017-08-11, disclosed to the SEC on 2017-08-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |
| TBPH | SELL | 2022-12-16 | $560K | — | Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |